Does this make ploinks obsolete before its even launched?
No doubt another secondary coming. Only question is conversion price. 2s, 3s? Board of directors: Does the CEO get to keep his job after this repeated CRL debacle?
Probably more like 2.50 -2.75 if they do a secondary raise. Seems that retail and institutions here have lost all confidence in this management. The board should do what's best for the company and replace the CEO with an experienced pharma exec who has taken products through FDA approval
It's the FDA, any scenario is possible. One can only hope the FDA has considered the monopoly Mylan has on this epi market and the need for a lower cost option
Yes. If approved by FDA, Allergan/Watson deals kicks in + US Compounding revenues in second quarter makes Adamis a profitable co.
who will the "puddle" partner (back up data device) be? HP, Dell etc?
Ok, chisel and stealth. Maybe some pressure to buy ahead of spinoff, obviously building being done, maybe some stealth, and yes, a new narrative to jabber about